• Arcturus Therapeutics' (ARCT) "Buy" Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 07 Jan 2025 07:26:15   America/Chicago


    Arcturus Therapeutics' (ARCT) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat January 7, 2025 Share Link copied to clipboard. Arcturus Therapeutics ( NASDAQ:ARCT - Get Free Report ) 's stock had its "buy" rating restated by H
    Read more...
Share on,